Alnylam Pharmaceuticals (ALNY) Cash from Operations (2009 - 2026)
Alnylam Pharmaceuticals posted quarterly Cash from Operations of 70504000.0 for Q1 2026, up 158.6% year-on-year from 27263625.41 in Q1 2025, and down 56.89% on a QoQ basis from 163555000.0 in Q4 2025.
Alnylam Pharmaceuticals (ALNY) has 18 years of Cash from Operations data on file, last reported at 70504000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 158.6% year-over-year to 70504000.0; the trailing twelve-month figure through Mar 2026 stood at 714896000.0 (up 1617.54% YoY), and the FY2025 full-year result was 524080000.0, up 6405.1% from the prior year.
- Cash from Operations for Q1 2026 stood at 70504000.0, down from 163555000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 359412000.0 in Q3 2023 and bottomed at 171193000.0 in Q1 2022.
- The 5-year median for Cash from Operations is 58986000.0 (2023), against an average of 8773764.71.
- The widest annual swing landed in 2024, when Cash from Operations plunged 217.71%; it then surged 643.84% in 2025.
- A 5-year view of Cash from Operations shows it stood at 131978000.0 in 2022, then jumped by 77.42% to 29795000.0 in 2023, then slumped by 217.71% to 94662000.0 in 2024, then surged by 272.78% to 163555000.0 in 2025, then plunged by 56.89% to 70504000.0 in 2026.
- The last three Cash from Operations figures came in at 70504000.0 (Q1 2026), 163555000.0 (Q4 2025), and 325109000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -354.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.50 Mn |
| Mar 31, 2026 | 70.50 Mn |
| Dec 31, 2025 | 163.56 Mn |
| Dec 31, 2025 | 163.56 Mn |
| Sep 30, 2025 | 325.11 Mn |
| Sep 30, 2025 | 325.11 Mn |
| Jun 30, 2025 | 155.73 Mn |
| Jun 30, 2025 | 155.73 Mn |
| Mar 31, 2025 | -120.31 Mn |
| Mar 31, 2025 | -120.31 Mn |
| Dec 31, 2024 | -94.66 Mn |
| Dec 31, 2024 | -94.66 Mn |
| Sep 30, 2024 | 43.71 Mn |
| Sep 30, 2024 | 43.71 Mn |
| Jun 30, 2024 | 124.16 Mn |
| Jun 30, 2024 | 124.16 Mn |
| Mar 31, 2024 | -81.52 Mn |
| Mar 31, 2024 | -81.52 Mn |
| Dec 31, 2023 | -29.80 Mn |
| Dec 31, 2023 | -29.80 Mn |
| Sep 30, 2023 | 359.41 Mn |
| Sep 30, 2023 | 359.41 Mn |
| Jun 30, 2023 | -58.99 Mn |
| Jun 30, 2023 | -58.99 Mn |
| Mar 31, 2023 | -166.48 Mn |
| Mar 31, 2023 | -166.48 Mn |
| Dec 31, 2022 | -131.98 Mn |
| Dec 31, 2022 | -131.98 Mn |
| Sep 30, 2022 | -115.28 Mn |
| Sep 30, 2022 | -115.28 Mn |
| Jun 30, 2022 | -122.82 Mn |
| Jun 30, 2022 | -122.82 Mn |
| Mar 31, 2022 | -171.19 Mn |
| Mar 31, 2022 | -171.19 Mn |
| Dec 31, 2021 | -150.14 Mn |
| Dec 31, 2021 | -150.14 Mn |
| Sep 30, 2021 | -134.04 Mn |
| Sep 30, 2021 | -134.04 Mn |
| Jun 30, 2021 | -121.86 Mn |
| Jun 30, 2021 | -121.86 Mn |
| Mar 31, 2021 | -235.66 Mn |
| Mar 31, 2021 | -235.66 Mn |
| Dec 31, 2020 | -123.14 Mn |
| Dec 31, 2020 | -123.14 Mn |
| Sep 30, 2020 | -110.33 Mn |
| Sep 30, 2020 | -110.33 Mn |
| Jun 30, 2020 | -135.33 Mn |
| Jun 30, 2020 | -135.33 Mn |
| Mar 31, 2020 | -246.16 Mn |
| Mar 31, 2020 | -246.16 Mn |
| Dec 31, 2019 | -195.98 Mn |
| Dec 31, 2019 | -195.98 Mn |
| Sep 30, 2019 | -182.63 Mn |
| Sep 30, 2019 | -182.63 Mn |
| Jun 30, 2019 | 288.70 Mn |
| Jun 30, 2019 | 288.70 Mn |
| Mar 31, 2019 | -188.51 Mn |
| Mar 31, 2019 | -188.51 Mn |
| Dec 31, 2018 | -150.46 Mn |
| Dec 31, 2018 | -150.46 Mn |
| Sep 30, 2018 | -153.81 Mn |
| Sep 30, 2018 | -153.81 Mn |
| Jun 30, 2018 | -102.69 Mn |
| Jun 30, 2018 | -102.69 Mn |
| Mar 31, 2018 | -155.66 Mn |
| Mar 31, 2018 | -155.66 Mn |
| Dec 31, 2017 | -103.04 Mn |
| Dec 31, 2017 | -103.04 Mn |
| Sep 30, 2017 | -98.36 Mn |
| Sep 30, 2017 | -98.36 Mn |
| Jun 30, 2017 | -81.05 Mn |
| Jun 30, 2017 | -81.05 Mn |
| Mar 31, 2017 | -100.33 Mn |
| Mar 31, 2017 | -100.33 Mn |
| Dec 31, 2016 | -78.34 Mn |
| Dec 31, 2016 | -78.34 Mn |
| Sep 30, 2016 | -75.54 Mn |
| Sep 30, 2016 | -75.54 Mn |
| Jun 30, 2016 | -70.21 Mn |
| Jun 30, 2016 | -70.21 Mn |
| Mar 31, 2016 | -83.62 Mn |
| Mar 31, 2016 | -83.62 Mn |
| Dec 31, 2015 | -53.06 Mn |
| Dec 31, 2015 | -53.06 Mn |
| Sep 30, 2015 | -54.37 Mn |
| Sep 30, 2015 | -54.37 Mn |
| Jun 30, 2015 | -55.46 Mn |
| Jun 30, 2015 | -55.46 Mn |
| Mar 31, 2015 | -26.26 Mn |
| Mar 31, 2015 | -26.26 Mn |
| Dec 31, 2014 | -36.64 Mn |
| Dec 31, 2014 | -36.64 Mn |
| Sep 30, 2014 | -40.71 Mn |
| Sep 30, 2014 | -40.71 Mn |
| Jun 30, 2014 | -46.63 Mn |
| Jun 30, 2014 | -46.63 Mn |
| Mar 31, 2014 | -41.68 Mn |
| Mar 31, 2014 | -41.68 Mn |
| Dec 31, 2013 | -22.37 Mn |
| Dec 31, 2013 | -22.37 Mn |
| Sep 30, 2013 | -21.72 Mn |
| Sep 30, 2013 | -21.72 Mn |
| Jun 30, 2013 | -23.60 Mn |
| Jun 30, 2013 | -23.60 Mn |
| Mar 31, 2013 | -971,000.00 |
| Mar 31, 2013 | -971,000.00 |
| Dec 31, 2012 | -68.91 Mn |
| Dec 31, 2012 | -68.91 Mn |
| Sep 30, 2012 | 5.21 Mn |
| Sep 30, 2012 | 5.21 Mn |
| Jun 30, 2012 | -21.69 Mn |
| Jun 30, 2012 | -21.69 Mn |
| Mar 31, 2012 | -30.22 Mn |
| Mar 31, 2012 | -30.22 Mn |
| Dec 31, 2011 | -25.16 Mn |
| Dec 31, 2011 | -25.16 Mn |
| Sep 30, 2011 | -29.03 Mn |
| Sep 30, 2011 | -29.03 Mn |
| Jun 30, 2011 | -26.58 Mn |
| Jun 30, 2011 | -26.58 Mn |
| Mar 31, 2011 | -6.31 Mn |
| Mar 31, 2011 | -6.31 Mn |
| Dec 31, 2010 | -20.39 Mn |
| Dec 31, 2010 | -20.39 Mn |
| Sep 30, 2010 | -24.04 Mn |
| Sep 30, 2010 | -24.04 Mn |
| Jun 30, 2010 | -24.31 Mn |
| Jun 30, 2010 | -24.31 Mn |
| Mar 31, 2010 | -15.60 Mn |
| Mar 31, 2010 | -15.60 Mn |
| Dec 31, 2009 | -16.87 Mn |
| Dec 31, 2009 | -16.87 Mn |
| Sep 30, 2009 | -20.59 Mn |
| Sep 30, 2009 | -20.59 Mn |